PTEN and prostate carcinoma: The pseudogene PTENP1 has been hypothesized to be biologically active in prostate cancer cells by competitively binding to miR-17, miR-19, miR-21, and miR-26 families to regulate the cellular levels of PTEN and exert a growth-suppressive effect [60].